213 related articles for article (PubMed ID: 20394471)
1. Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitis.
Paglia M; Peterson J; Fisher AC; Qin Z; Nicholson SC; Kahn JB
Curr Med Res Opin; 2010 Jun; 26(6):1433-41. PubMed ID: 20394471
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.
Bergallo C; Jasovich A; Teglia O; Oliva ME; Lentnek A; de Wouters L; Zlocowski JC; Dukart G; Cooper A; Mallick R;
Diagn Microbiol Infect Dis; 2009 Jan; 63(1):52-61. PubMed ID: 18990531
[TBL] [Abstract][Full Text] [Related]
3. Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis.
Naber KG; Roscher K; Botto H; Schaefer V
Int J Antimicrob Agents; 2008 Aug; 32(2):145-53. PubMed ID: 18571904
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
[TBL] [Abstract][Full Text] [Related]
5. Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination.
Jeong CW; Lim DJ; Son H; Lee SE; Jeong H
Urol Int; 2008; 80(2):157-61. PubMed ID: 18362485
[TBL] [Abstract][Full Text] [Related]
6. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
Schwab IR; Friedlaender M; McCulley J; Lichtenstein SJ; Moran CT;
Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805
[TBL] [Abstract][Full Text] [Related]
7. [Corticoid combined with an antibiotic for chronic nonbacterial prostatitis].
Yang MG; Zhao XK; Wu ZP; Xiao N; Lü C; Hou Y
Zhonghua Nan Ke Xue; 2009 Mar; 15(3):237-40. PubMed ID: 19452696
[TBL] [Abstract][Full Text] [Related]
8. Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.
Henry DC; Kapral D; Busman TA; Paris MM
Clin Ther; 2004 Dec; 26(12):2026-33. PubMed ID: 15823766
[TBL] [Abstract][Full Text] [Related]
9. Identification, pharmacologic considerations, and management of prostatitis.
Schiller DS; Parikh A
Am J Geriatr Pharmacother; 2011 Feb; 9(1):37-48. PubMed ID: 21459307
[TBL] [Abstract][Full Text] [Related]
10. Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
Schaeffer AJ; Wu SC; Tennenberg AM; Kahn JB
J Urol; 2005 Jul; 174(1):161-4. PubMed ID: 15947609
[TBL] [Abstract][Full Text] [Related]
11. Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy.
Anzueto A; Niederman MS; Pearle J; Restrepo MI; Heyder A; Choudhri SH;
Clin Infect Dis; 2006 Jan; 42(1):73-81. PubMed ID: 16323095
[TBL] [Abstract][Full Text] [Related]
12. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis.
Nickel JC; Pontari M; Moon T; Gittelman M; Malek G; Farrington J; Pearson J; Krupa D; Bach M; Drisko J;
J Urol; 2003 Apr; 169(4):1401-5. PubMed ID: 12629372
[TBL] [Abstract][Full Text] [Related]
13. [Etiotropic therapy of chronic bacterial prostatitis].
Popov SV; Mazo EB
Urologiia; 2008; (3):36, 38-41. PubMed ID: 18669346
[TBL] [Abstract][Full Text] [Related]
14. A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media.
Noel GJ; Blumer JL; Pichichero ME; Hedrick JA; Schwartz RH; Balis DA; Melkote R; Bagchi P; Arguedas A
Pediatr Infect Dis J; 2008 Jun; 27(6):483-9. PubMed ID: 18449063
[TBL] [Abstract][Full Text] [Related]
15. Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia.
Tanaseanu C; Bergallo C; Teglia O; Jasovich A; Oliva ME; Dukart G; Dartois N; Cooper CA; Gandjini H; Mallick R; ;
Diagn Microbiol Infect Dis; 2008 Jul; 61(3):329-38. PubMed ID: 18508226
[TBL] [Abstract][Full Text] [Related]
16. [A clinical study of prostat combined with an antibiotic for chronic nonbacterial prostatitis].
Ye ZQ; Lan RZ; Wang SG; Cai SL; Chen GM; Li NC; Song Y; Na YQ
Zhonghua Nan Ke Xue; 2006 Sep; 12(9):807-10. PubMed ID: 17009533
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
Bradley JS; Arguedas A; Blumer JL; Sáez-Llorens X; Melkote R; Noel GJ
Pediatr Infect Dis J; 2007 Oct; 26(10):868-78. PubMed ID: 17901791
[TBL] [Abstract][Full Text] [Related]
18. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
Schwartz RH
Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
[TBL] [Abstract][Full Text] [Related]
19. Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
Torres A; Garau J; Arvis P; Carlet J; Choudhri S; Kureishi A; Le Berre MA; Lode H; Winter J; Read RC;
Clin Infect Dis; 2008 May; 46(10):1499-509. PubMed ID: 18419482
[TBL] [Abstract][Full Text] [Related]
20. [Longqingpian combined with levofloxacin highly effective for type IIIA prostatitis].
Xu H; Shang XJ; Cai X; Teng WH; Huang YF
Zhonghua Nan Ke Xue; 2007 Apr; 13(4):338-41. PubMed ID: 17491269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]